Y Kawai, Y Kato, D Nakae, O Kusuoka, Y Konishi, K Uchida, T Osawa
CARCINOGENESIS 23(3) 485-489 2002年3月 査読有り
Endogenous lipid peroxidation products react with DNA and form exocyclic DNA adducts. The purpose of this study was to investigate the in vivo formation of 7-(2-oxo-heptyl)-substituted 1,N-2-etheno-2'-deoxyguanosine adduct (Oxo-heptyl-epsilondG), one of the major products from the reaction of 13-hydroperoxyoctadecadienoic acid (13-HPODE) with dG. The monoclonal antibody specific to Oxo-heptyl-epsilondG was prepared using a chemically synthesized conjugate of Oxo-heptyl-epsilondG and carrier protein as immunogen. The characterization showed that the obtained antibody (mAb6A3) is specific to the Oxo-heptyl-epsilondG moiety. Using the novel antibody, the presence of the Oxoheptyl-epsilondG adduct in vivo was immunohistochemically revealed in the liver of rats fed a choline-deficient, L-amino acid-defined diet, an endogenous carcinogenesis model, for 3 days. In addition, the Oxo-heptyl-epsilondG formation was confirmed in DNAs treated with peroxidized linoleic acid, arachidonic acid and gamma-linolenic acid, respectively, suggesting that the hydroperoxides of omega-6 polyunsaturated fatty acids could be the potential sources of Oxo-heptyl-epsilondG formation in vivo. Collectively, the results in this study suggest the first evidence that the formation of Oxo-heptyl-epsilondG, the omega-6 lipid hydroperoxide-mediated DNA adduct, may be a potential biomarker for the early phase of carcinogenesis.